Association between alzheimer’s disease and apoe gene genotypic polymorphisms: systematic review and meta-analysis / Associação entre doença de alzheimer e polimorfismos genotipicos do gene apoe: revisão sistemática e metanálise

Mateus Gonçalves Pereira, Lucas Cândido Gonçalves, Paulo Alex Neves da Silva, Mônica Nunes da Costa, Regineide de Fátima Macêdo Barbosa, Lilian Carla Carneiro, Adailton Pereira dos Santos, Xisto Sena Passos, Milton Camplesi Junior, Fábio Silvestre Ataídes, Antonio Márcio Teodoro Cordeiro Silva, Fábio Marques de Almeida

Abstract


Introduction- Alzheimer's disease (AD) is classified as neurodegenerative, progressive and irreversible and is clinically characterized by a progressive decline in neurological functions. Objective- To evaluate the association among the genotypic variations of the APOE gene with Alzheimer's Disease. Methods- This is a systematic review and meta-analysis, and, according to the inclusion criteria, 59 articles were selected from the PubMed, Latin American and Caribbean Literature in Health Sciences (LILACS) and Scientific databases Electronic Library Online (SciELO) and of this total, 22 contributed data for systematic review and meta-analysis. Statistical tests were performed with the aid of the STATA® 16.0 software, considering the significance limit equal to 5% (p-value = 0.05). Thus, the DerSimonian-Laird and Mantel Haenszel tests were applied according to heterogeneity, for the evaluation of Odds Ratios (OR). Results- The results showed an association of predisposition to the development of AD, considering the genotypes Ԑ3Ԑ4 and Ԑ4Ԑ4, respectively OR = 2.63 (95% CI = 2.18-318) and OR = 5.37 (95% CI = 3.57- 8.08), on the other hand, the genotypes Ԑ2Ԑ3 and Ԑ3Ԑ3, showed association as a protective factor against AD, respectively OR = 0.49 (95% CI = 0.42-0.57) and OR = 0.53 (95% CI = 0.42-0.68). Conclusion- The present meta-analysis showed a strong association of risk to AD when the genotype Ԑ4Ԑ4 and genotype Ԑ3Ԑ4 were evaluated, on the other hand, there was an association of protection to AD for Ԑ2Ԑ3 and Ԑ3Ԑ3. The other genotypes showed no association.

 


Keywords


Alzheimer's Disease, Polymorphism, Apoe Gene, Genotype.

References


Alzheimer A. Uber eine eigenartige Erkrankung der Hirnrinde. Allg Zeitschrift Psychiatr. 1907;64(1):146–8.

Risso DT, Triches JR, Piccinini AM, Tuni DC. Assessment of the difficulties and burden of caregivers of people with Alzheimer's disease. Brazilian Journal of Development. 2021;7(5):2004–12.

Alzheimer’s Association Report. 2018 Alzheimer’s disease facts and figures. Alzheimer’s Dement. 2018;14(3):367–429.

Bertolucci PHF, Ferraz HB, Barsottini OGP, Pedroso JL. Neurologia: diagnóstico e tratamentos. 2° ed. Barueri/SP: Manope; 2016.

Durmaz A, Kumral E, Durmaz B, Onay H, Aslan GI, Ozkinay F, et al. Genetic factors associated with the predisposition to late onset Alzheimer’s disease. Gene. 2019;707(March):212–15.

OMS. Organização Mundial da Saúde [Internet]. Glob. Dement. Obs. 2020 [cited 2020 Aug 13];2. Available from: apps.who.int/gho/data/node.dementia

Rasmussen J, Langerman H. Alzheimer ’ s Disease – Why We Need Early Diagnosis. Degener. Neurol. Neuromuscul. Dis. 2019;9(2):123–30.

Mahley RW. Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders. J. Mol. Med. 2016;94(7):739–46.

Shao W, Peng D, Wang X. Genetics of Alzheimer’s disease: From pathogenesis to clinical usage. J. Clin. Neurosci. 2017;45(1):1–8.

Seripa D, Onofrio GD, Panza F, Cascavilla L, Masullo C, Pilotto A. The Genetics of the Human APOE Polymorphism. Rejuvenation Res. 2011;14(5):491–500.

Hickman RA, Faustion A, Wisniewski T. Alzheimer Disease and Its Growing Epidemic. Neurol. Clin. 2016;941–53.

Khabour OF, Abdelhalim ES. Distribution of APOE gene variations in the Jordanian population: Association with longevity. J. King Saud Univ. - Sci. 2020;32(1):518–22.

Svobodová H, Kucera F, Stulc T, Vrablík M, Amartuvshin B, Altannavch T, et al. Apolipoprotein E Gene Polymorphism in the Mongolian Population. Folia Biol. (Praha). 2007;53(March):138–42.

Fan L, Mao C, Hu X, Zhang S, Yang Z, Hu Z, et al. New Insights Into the Pathogenesis of Alzheimer’s Disease. Front. Neurol. 2020;10(January):1–12.

Lautner R, Palmqvist S, Mattsson N, Andreasson U, Wallin A, Pålsson E, et al. Apolipoprotein e genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for alzheimer disease. JAMA Psychiatry. 2014;71(10):1183–91.

Kim J, Basak JM, Holtzman DM. The Role of Apolipoprotein E in Alzheimer ’ s Disease. Neuron. 2009;63(3):287–303.

Robinson M, Lee BY, Hane FT. Recent Progress in Alzheimer ’ s Disease Research , Part 2 : Genetics and Epidemiology. J. Alzheimer’s Dis. 2017;57(January):317–30.

Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred Reporting Items for Systematic Reviews and Meta-Analyses : The PRISMA Statement. PLoS Med. 2009;6(7):1–6.

Santos EJF dos, Cunha M. Critical interpretation of statistical results of a meta-Analysis: methodological strategeis. Millenium. 2013;44(Janeiro/junho):85–98.

de-Andrade FM, Larrandaburu M, Callegari-Jacques SM, Gastaldo G, Hutz MH. Association of apolipoprotein E polymorphism with plasma lipids and Alzheimer’s disease in a Southern Brazilian population. Brazilian J. Med. Biol. Res. 2000 May;33(5):529–37.

Arboleda GH, Yunis JJ, Pardo R, Go CM, Hedmont D, Arango G, et al. Apolipoprotein E genotyping in a sample of Colombian patients with Alzheimers disease. Neurosci. Lett. 2001;305:1–3.

Kim HC, Kim DK, Choi IJ, Kang KH, Yi S Do, Park J, et al. Relation of apolipoprotein E polymorphism to clinically diagnosed Alzheimer’s disease in the Korean population. Psychiatry Clin. Neurosci. 2001;55(2):115–20.

Graff-Radford NR, Green RC, Go RCP, Hutton ML, Edeki T, Bachman D, et al. Association between apolipoprotein E genotype and Alzheimer disease in African American subjects. Arch. Neurol. 2002;59(4):594–600.

Souza DRS, Godoy MR De, Hotta J, Tajara EH, Brandão AC, Júnior SP, et al. Association of apolipoprotein E polymorphism in late-onset Alzheimer ’ s disease and vascular dementia in Brazilians. Brazilian J. Med. Biol. Res. 2003;36(7):919–23.

Rakonczay Z, Horváth Z, Juhász A, Kálmán J. Peripheral cholinergic disturbances in Alzheimer’s disease. Chem. Biol. Interact. 2005;157–8(1):233–8.

Murrell JR, Price B, Lane KA, Baiyewu O, Gureje O, Ogunniyi A, et al. Association of apolipoprotein E genotype and Alzheimer disease in African Americans. Arch. Neurol. 2006;63(3):431–4.

Gureje O, Ogunniyi A, Baiyewu O, Price B, Unverzagt FW, Evans RM, et al. APOE ε4 is not associated with Alzheimer’s disease in elderly Nigerians. Ann. Neurol. 2006;59(1):182–5.

Bahia VS, Kok F, Marie SN, Shinjo SO, Caramelli P, Nitrini R. Polymorphisms of APOE and LRP genes in Brazilian individuals with Alzheimer disease. Alzheimer Dis. Assoc. Disord. 2008;22(1):61–5.

Bizzarro A, Seripa D, Acciarri A, Matera MG, Pilotto A, Tiziano FD, et al. The complex interaction between APOE promoter and AD: An Italian case-control study. Eur. J. Hum. Genet. 2009;17(7):938–45.

Takei N, Miyashita A, Tsukie T, Arai H, Asada T, Imagawa M, et al. Genetic association study on in and around the APOE in late-onset Alzheimer disease in Japanese. Genomics. 2009;93(5):441–8.

Kobayashi S, Tateno M, Park TW, Utsumi K, Sohma H, Ito YM, et al. Apolipoprotein E4 frequencies in a Japanese population with Alzheimer’s disease and dementia with Lewy bodies. PLoS One. 2011;6(4):2–6.

Almada BVP de, Almeida LD de, Camporez D, De-Moraes M V.D., Morelato RL, Perrone AMS, et al. Protective effect of the APOE-e3 allele in Alzheimer’s disease. Brazilian J. Med. Biol. Res. 2012;45(1):8–12.

Rassas AA, Khiari HM, Fredj SH, Sahnoun S, Batti H, Zakraoui NO, et al. High APOE epsilon 4 allele frequencies associated with Alzheimer disease in a Tunisian population. Neurol. Sci. 2012;33(1):33–7.

Singh NK, Chhillar N, Banerjee BD, Bala K, Mukherjee AK, Mustafa MD, et al. Gene-environment interaction in Alzheimer’s disease. Am. J. Alzheimers. Dis. Other Demen. 2012;27(7):496–503.

Zhou X, Miao H, Rausch WD, Long M, Luo X, Yu H, et al. Association between apolipoprotein E gene polymorphism and Alzheimer’s disease in Uighur and Han populations. Psychogeriatrics. 2012;12(2):83–7.

Kumar NT, Liestøl K, Løberg EM, Reims HM, Mæhlen J. Apolipoprotein E allelotype is associated with neuropathological findings in Alzheimer’s disease. Virchows Arch. 2015;467(2):225–35.

Wu P, Li HL, Liu ZJ, Tao QQ, Xu M, Guo QH, et al. Associations between apolipoprotein e gene polymorphisms and Alzheimer’s disease risk in a large Chinese Han population. Clin. Interv. Aging. 2015;10(1):371–8.

Ghayeghran AR, Akbarshahi M, Salehi Z, Davoudi-Kiakalayeh A. Analysis of apolipoprotein E genetic variation in patients with Alzheimer disease referred to Imam Reza Clinic, Rasht, Iran, in 2015. Iran. J. Neurol. 2017;16(4):173–7.

Bratosiewicz-Wasik J, Liberski PP, Peplonska B, Styczynska M, Smolen-Dzirba J, Cycon M, et al. Regulatory region single nucleotide polymorphisms of the apolipoprotein E gene as risk factors for Alzheimer’s disease. Neurosci. Lett. 2018;684(March):86–90.

Zhou L, Li HY, Wang JH, Deng ZZ, Shan YL, Tan S, et al. Correlation of gene polymorphisms of CD36 and ApoE with susceptibility of Alzheimer disease: A case-control study. Med. (United States). 2018;97(38):1–6.

Reitz C, Brayne C, Mayeux R. Epidemiology of Alzheimer disease. Nat. Rev. Neurol. 2011;7(3):137–52.

Patterson C. World Alzheimer Report 2018 The state of the art of dementia research: New frontiers. 2018.

Barber RC. Biomarkers for early detection of Alzheimer disease. J. Am. Osteopath. Assoc. 2010;110(9 SUPPL. 8):10–5.

Barros AC, Lucatelli JF, Maluf SW, Andrade FM De. Genetic influence on late onset Alzeimer’s disease. Rev. Psiquiatr. Clin. 2009;36(1):16–24.

Zhen J, Huang X, Halm-Lutterodt N Van, Dong S, Ma W, Xiao R, et al. ApoE rs429358 and rs7412 polymorphism and gender differences of serum lipid profile and cognition in aging Chinese population. Front. Aging Neurosci. 2017;9(248):1–10.

Lahiri DK, Sambamurti K, Bennett DA. Apolipoprotein gene and its interaction with the environmentally driven risk factors : molecular , genetic and epidemiological studies of Alzheimer ’ s disease. Neurobiol. Aging. 2004;25(December):651–60.

Yin Y, Wang Z. ApoE and Neurodegenerative Diseases in Aging. Nat. Singapore. 2018;1086(2):77–92.

Mehrabian S, Alexopoulos P, Ortner M, Traykov L, Grimmer T, Kurz A, et al. Cerebrospinal fluid biomarkers for Alzheimer’s disease: The role of apolipoprotein E genotype, age, and sex. Neuropsychiatr. Dis. Treat. 2015;11(1):3105–10.

Jeong S. Molecular and Cellular Basis of Neurodegeneration in Alzheimer’s Disease. Mol. Cells. 2017;40(9):613–20.

Yamazaki Y, Zhao N, Caulfield TR, Liu CC, Bu G. Apolipoprotein E and Alzheimer disease: pathobiology and targeting strategies. Nat. Rev. Neurol. 2019;15(9):501–18.

Moustafa AA, Hassan M, Hewedi DH, Hewedi I, Garami JK, Ashwal H Al, et al. Genetic underpinnings in Alzheimer’s disease - A review. Rev. Neurosci. 2017;29(1):21–38.

Koran MEI, Wagener M, Hohman TJ. Sex differences in the association between AD biomarkers and cognitive decline. Brain Imaging Behav. 2017;11(1):205–13.

Uddin MS, Kabir MT, Mamun A Al, Abdel-Daim MM, Barreto GE, Ashraf GM. APOE and Alzheimer’s Disease: Evidence Mounts that Targeting APOE4 may Combat Alzheimer’s Pathogenesis. Mol. Neurobiol. 2019;56(4):2450–65.

Garcia AN, Silva HA Da, Silva RC, Leal EMM, Rodrigues L, Silva VC Da, et al. APOE-ε4 polymorphism and cognitive deficit among the elderly population of Fernando de Noronha. Arq. Neuropsiquiatr. 2008;66(2 B):298–302.

Ward A, Crean S, Mercaldi CJ, Collins JM, Boyd D, Cook MN, et al. Prevalence of Apolipoprotein E4 genotype and homozygotes (APOE e4/4) among patients diagnosed with alzheimer’s disease: A systematic review and meta-analysis. Neuroepidemiology. 2012;38(1):1–17.

Demarchi DA, Salzano FM, Altuna ME, Fiegenbaum M, Hill K, Hurtado AM, et al. APOE polymorphism distribution among Native Americans and related populations. Ann. Hum. Biol. 2005;32(3):351–65.

Reitz C. Genetic diagnosis and prognosis of Alzheimer’s disease: Challenges and opportunities. Expert Rev. Mol. Diagn. 2015;15(3):339–48.

Nho K, Kim S, Horgusluoglu E, Risacher SL, Shen L, Kim D, et al. Association analysis of rare variants near the APOE region with CSF and neuroimaging biomarkers of Alzheimer’s disease. BMC Med. Genomics. 2017;10(Suppl 1):45–52.

Weller J, Budson A. Current understanding of Alzheimer’s disease diagnosis and treatment. F1000Research. 2018;7(1161):1–9.




DOI: https://doi.org/10.34117/bjdv7n6-391

Refbacks

  • There are currently no refbacks.